BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2014 Financial Results 8/11/2014 7:46:30 AM
Immunomedics, Inc. (IMMU) Release: Scientific Data On Epratuzumab In Systemic Lupus Erythematosus To Be Presented At EULAR 2014 6/9/2014 9:11:24 AM
Immunomedics, Inc. (IMMU) Announces Orphan Drug Designation For IMMU-132 For Pancreatic Cancer Therapy 6/9/2014 8:59:56 AM
Immunomedics, Inc. (IMMU) Reports Development Of Improved Cancer Immunotherapy At The 2014 Annual Meeting Of The American Society of Clinical Oncology 6/2/2014 9:50:09 AM
Immunomedics, Inc. (IMMU) Reports Final Efficacy Results Of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan In Patients With Metastatic Pancreatic Cancer 6/2/2014 9:47:50 AM
Immunomedics, Inc. (IMMU) Reports IMMU-130 Is Active In Patients With Irinotecan-Refractory Colorectal Cancer 6/2/2014 9:21:27 AM
Immunomedics, Inc. (IMMU) To Present At Upcoming Healthcare Conferences 5/29/2014 9:21:21 AM
Immunomedics, Inc. (IMMU) Reports Results With IMMU-132 In Patients With Pancreatic Cancer 5/21/2014 9:27:02 AM
Immunomedics, Inc. (IMMU) Reports Results With IMMU-132 In Patients With Pancreatic Cancer 5/20/2014 11:53:30 AM
Immunomedics, Inc. (IMMU) Reports Updated Results With 90Y-Clivatuzumab Tetraxetan In Patients With Metastatic Pancreatic Cancer 5/19/2014 9:19:53 AM
12345678910...